In what follows, we first explain the pharmacy vs medical benefit framework, then review GLP-1 drugs and their coverage in Medicaid, Medicare, and commercial plans, interweaving data, policy developments, and real-world examples throughout
A multi-strain probiotic increased butyrate-induced GLP-1 in a landmark study, and species including Lactobacillus reuteri , Bifidobacterium breve , and Lactobacillus gasseri have been examined in human trials
It is important to note that semaglutide is not approved for use with type 1 diabetes or diabetic ketoacidosis
TDM was supported for this work by funding from the German Research Foundation (DFG TRR296, TRR152, SFB1123, and GRK 2816/1), the German Center for Diabetes Research (DZD e.V.) and the European Research Council ERC-CoG Trusted no.101044445
Youve read the science, but applying it to your own life can be confusing